EVALUATION OF 6 COMPUTERIZED DRUG-INTERACTION SCREENING PROGRAMS
EVALUATION OF 6 COMPUTERIZED DRUG-INTERACTION SCREENING PROGRAMS
复制标题
DOI：
10.1093/ajhp/49.6.1430
复制
发表时间：
1992-06-01
期刊：
影响因子：
--
通讯作者：
JANKEL, CA
中科院分区：
文献类型：
--
作者：
JANKEL, CA
根据一个由药剂师组成的小组制定的标准，对6种广泛使用的计算机化药物相互作用筛选程序进行了评价。一个由来自不同实践环境的6名药剂师组成的小组制定了用于评价6种计算机化药物相互作用筛选程序的标准：Medicom Micro Plus、Medical Letter、S-O-A-P、Hansten的药物相互作用、药物治疗筛选系统（DTSS）和Rx Triage。标准是，程序是用户友好和高效的，提供指导，并与用户的做法设置。此外，它们应该检测交互，快速提醒用户，并引导用户采取适当的操作。用户应该能够设置临床显著性水平，仅筛选患者配置文件中的当前药物，并打印摘要。该小组选择了9种已知的药物相互作用来测试程序的知识库。只有Medicom Micro Plus和DTSS检测到了所有9种药物相互作用; Medical Letter遗漏了3种。RxTriage和药物相互作用在用户友好性和效率方面获得了最高评级，但两者都错过了两次相互作用。RxTriage被医院和社区药剂师评为与他们的实践最相关，药物相互作用被教师从业者评为最相关。S-O-A-P总体评价较低，在评价的6个药物相互作用筛查项目中，没有一个被药剂师小组认为是理想的。
Six widely used computerized drug interaction screening programs were evaluated according to criteria developed by a panel of pharmacists.A panel of six pharmacists from various practice settings developed criteria that were used to evaluate six computerized drug interaction screening programs: Medicom Micro Plus, Medical Letter, S-O-A-P, Drug Interactions by Hansten, Drug Therapy Screening Systems (DTSS), and RxTriage. The criteria were that the programs be user friendly and efficient, provide guidance, and be relevant to the user's practice setting. Also, they should detect interactions, quickly alert the user, and guide the user to the appropriate action. The user should be able to set the level of clinical significance, screen only current drugs in a patient profile, and print out summaries. The panel selected nine known drug interactions to test the programs' knowledge bases.Only Medicom Micro Plus and DTSS detected all nine drug interactions; Medical Letter missed three. RxTriage and Drug Interactions received the highest ratings in user friendliness and efficiency, but both missed two interactions. RxTriage was rated most relevant to their practice by hospital and community pharmacists, and Drug Interactions was rated most relevant by faculty practitioners. S-O-A-P received low ratings overall.Of the six drug interaction screening programs evaluated, none was considered by the panel of pharmacists to be ideal.